Clinical Trials for CellSight Technologies

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CellSight Technologies

Clinical Trials (6)

NCT07168785
[18F]-AraG PET Imaging in LA HNSCC
EARLY_PHASE1Not yet recruiting
5 participants
Started: Oct 1, 2025 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT06107374
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
PHASE2Recruiting
20 participants
Started: Nov 1, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06084806
Test-retest Evaluation of [18F]F-AraG PET
PHASE2Recruiting
10 participants
Started: Oct 31, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT04260256
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
PHASE2Recruiting
40 participants
Started: Mar 1, 2022 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT04815096
Imaging Immune Activation in COVID-19
PHASE2Recruiting
80 participants
Started: Apr 15, 2021 · Completed: Oct 1, 2025
2 conditions2 sponsors1 location
NCT03684655
Imaging Immune Activation in HIV by PET-MR
PHASE2Recruiting
30 participants
Started: Sep 21, 2018 · Completed: Nov 1, 2025
1 condition3 sponsors1 location